Keywords: bayer, licenses, antigen, rights, dendreon, germany, entered

Bayer licenses antigen rights to Dendreon

Article | 28 September 2001

Print This

Germany's Bayer has entered into an agreement with Dendreon Corp of theUSA to license two prominent tumor antigens for use ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in